Skip to content
SentinelMarket desk
Switch to dark mode

EDGC

245620KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

741KRWMarket close of 10/21 (Wed)

No trade that dayMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)741KRWFlat 0.00%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Volume
0×10K shares
0 KRW

Open, high and low are not shown — the source has no bar for the reference date

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 353 to 2,145 won, 3% up from the low

3% of the way up from the lowest close in 1 year (252 sessions) · -80.7% from the high

Something to check

2 to check: no trades this day · operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveto checkNo trades this day (0 shares)
  • Earningsto check-1.4B KRWOperating income over the last four quarters -1.4B KRW (loss)Operating income, 8 quarters
  • Trading valuenot verifiedNo trading that day, so not compared with usual trading value

The other 3

  • Recent filingsnot verified
  • Foreign & institutionalnot verified
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue1.6B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -67.4%
    vs. prior quarter
    Turned profitable
  • Operating income-1.3B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Turned to loss
  • Operating margin-81.4%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -50.4 pp
    vs. prior quarter
    —

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15
2021Q1 -2.8B KRW2026Q1 -1.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.